LifeStance Health Group, Inc. beat EPS estimates 69% of the time across 16 reported quarters (11 beats, 5 misses), averaging +10.5% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $0.03 | $0.06 | +100.0% | Beat | Q2 FY26 call |
| Q1 FY26 | not reported | $0.04 | not reported | not reported | |
| Q4 FY25 | $0.00 | $0.03 | not reported | Beat | |
| Q3 FY25 | $-0.01 | $0.00 | +100.0% | Beat | |
| Q2 FY25 | not reported | $-0.01 | not reported | not reported | |
| Q1 FY25 | $-0.04 | $0.00 | +100.0% | Beat | |
| Q4 FY24 | $-0.04 | $-0.02 | +50.0% | Beat | |
| Q3 FY24 | not reported | $-0.02 | not reported | not reported | |
| Q2 FY24 | $-0.07 | $-0.06 | +14.3% | Beat | |
| Q1 FY24 | $-0.09 | $-0.06 | +33.3% | Beat | |
| Q4 FY23 | $-0.09 | $-0.12 | -33.3% | Miss | |
| Q3 FY23 | $-0.07 | $-0.17 | -142.9% | Miss |
Back to LFST overview · LFST holders · LFST KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.